Predictive factors of delayed viral clearance of asymptomatic Omicron-related COVID-19 screened positive in patients with cancer receiving active anticancer treatment.

Authors:
Lee VH; Chan SK; Tam YH; Chau TC; Chan JFW and 5 more

Journal:
Int J Infect Dis

Publication Year: 2023

DOI:
10.1016/j.ijid.2023.04.397

PMCID:
PMC10105908

PMID:
37072051

Journal Information

Full Title: Int J Infect Dis

Abbreviation: Int J Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest VHFL reported receiving personal fees and grants from AstraZeneca and personal fees from AQUILAB, Amgen, Boston Scientific, Eli Lilly, Merck Sharp and Dohme, Novartis, Pfizer, and Takeda outside the submitted work. All other authors have no competing interests to declare."

Evidence found in paper:

"Funding The authors declare that no funds, grants, or other support were received during the preparation of this manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025